Company Loxo Oncology Inc
Equities
US5488621013
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 39 | 14-04-30 | |
President | - | - | |
Anthony Sireci
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Liz Beja
COO | Chief Operating Officer | - | - |
David Hyman
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Compliance Officer | - | 18-03-31 | |
Human Resources Officer | - | - | |
Amy Rose
HRO | Human Resources Officer | - | 19-12-31 |
Philip Johnson
LAW | General Counsel | - | 20-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 30,614,536 | 29,481,314 ( 96.30 %) | 0 | 96.30 % |
Company contact information
Loxo Oncology, Inc.
281 Tresser Boulevard 9th floor
06901, Stamford
+203-653-3880
http://www.loxooncology.com![address Loxo Oncology Inc](https://cdn.zonebourse.com/static/address/17068136.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.63% | 126B | |
+24.16% | 27.95B | |
-20.17% | 20.5B | |
-16.06% | 17.12B | |
-18.07% | 16.1B | |
-47.70% | 14.97B | |
+11.92% | 14.84B | |
+58.32% | 14.38B | |
+149.98% | 12.37B |